HIM
TARO

Hillsdale Investment Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Hillsdale Investment Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-60
Closed -$6K – 548
2016
Q4 		$6K Hold
60
– – ﹤0.01% 384
2016
Q3 		$7K Hold
60
– – ﹤0.01% 406
2016
Q2 		$9K Sell
60
-200
-77% -$28.4K ﹤0.01% 401
2016
Q1 		$38K Sell
260
-20
-7% -$2.84K 0.01% 342
2015
Q4 		$43K Sell
280
-2,300
-89% -$336K 0.02% 346
2015
Q3 		$369K Sell
2,580
-300
-10% -$41.9K 0.12% 154
2015
Q2 		$414K Buy
2,880
+200
+7% +$28.5K 0.13% 149
2015
Q1 		$378K Buy
2,680
+700
+35% +$108K 0.1% 185
2014
Q4 		$293K Sell
1,980
-200
-9% -$29.4K 0.08% 247
2014
Q3 		$335K Sell
2,180
-600
-22% -$90.3K 0.11% 155
2014
Q2 		$390K Sell
2,780
-300
-10% -$33.3K 0.09% 138
2014
Q1 		$342K Sell
3,080
-220
-7% -$23.9K 0.1% 148
2013
Q4 		$326K Sell
3,300
-600
-15% -$52K 0.1% 163
2013
Q3 		$296K Buy
+3,900
New +$253K 0.09% 200

Other funds holding TARO

MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FL
Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Hillsdale Investment Management's TARO Position: Q1 2017 in Review

Hillsdale Investment Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2017, closing a stake of 60 shares — an estimated $6K sold.

Hillsdale Investment Management first reported a position in TARO in Q3 2013 and held it in 14 quarters. The position peaked at $414K in Q2 2015. 139 funds tracked by Wall St. Rank hold TARO as of Q1 2017.

  • Hillsdale Investment Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2017 after selling out during the quarter.
  • Hillsdale Investment Management sold 60 Taro Pharmaceutical Industries Ltd. shares in Q1 2017, an estimated $6K.
  • Hillsdale Investment Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2013 and held it in 14 quarters.
  • Hillsdale Investment Management's Taro Pharmaceutical Industries Ltd. position peaked at $414K in Q2 2015.
  • 139 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2017.

Based on Hillsdale Investment Management's 13F filing for Q1 2017, filed 9 May 2017.